The common heart condition affects approximately 1.5 million people in the UK More: UK study highlights importance of GP data in understanding atrial fibrillation Source: News
read moreAfter making a pledge on vaccines to Sen. Bill Cassidy during his confirmation process, HHS Secretary Robert F. Kennedy Jr. has promptly reversed course. Now enthroned at the HHS, RFK Jr. has pledged to kick off an investigation into childhood
read moreTo support the launch of Tryngolza, which is approved to treat adults with familial chylomicronemia syndrome, Ionis recently kicked off a pair of omnichannel marketing efforts. The campaigns, “Tame It With Tryngolza” and “It’s Time to Celebrate,” are tailored to
read moreThe agency responded to Harmony’s bid for an idiopathic hypersomnia nod for excessive daytime sleepiness med Wakix with a refusal to file letter after a missed phase 3 study. More: FDA disrupts Harmony's expansion dreams for excessive sleepiness drug Wakix
read moreAfter Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. More: Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants Source:
read moreBristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperative treatment for non-small cell lung cancer (NSCLC) as it has delivered an overall survival (OS) edge when added to chemotherapy. More: Bristol Myers Squibb notches
read more© 1994 - 2025 B.M. Pharmaceuticals